OneMedPlace Research Releases Update to Research Report on Amarantus ... ( SUNNYVALE Calif. Feb. 6 2013...)

OneMedPlace Research Releases Update to Research Report on Amarantus BioScience

Date:2/6/2013

SUNNYVALE, Calif., Feb. 6, 2013 /PRNewswire/ -- Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with the neurodegeneration and apoptosis centered around its patented therapeutic protein MANF, today announced that OneMedPlace Research has released an update to its initial research report on the Company, with a specific focus on data released on Amarantus' lead drug candidate MANF in a standard animal model of Parkinson's disease and the Company's recent acquisition of a portfolio of diagnostic tests from Power3 Medical Products. The report is available online at http://www.onemedplace.com/blog/wp-content/uploads/2013/02/Amarantus-February-Update.pdf.

About Amarantus BioScience, Inc.

Amarantus BioScience, Inc. is a development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat and/or diagnose Parkinson's disease, Traumatic Brain Injury, Ischemic Heart Disease and other human diseases. The Company owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. The Company also is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property and licenses for the diagnosis of Parkinson's disease and Alzheimer's disease. For further information please visit www.Amarantus.co
'/>"/>

SOURCE Amarantus BioScience, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. OneMedPlace Releases Update to Research Report on Amarantus Biosciences Focused on New Positive Ischemic Heart Disease Efficacy Data for MANF in Animals
2. Wolters Kluwer Research Now Available via Bloomberg Tradebook
3. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
4. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
5. Researching graphene nanoelectronics for a post-silicon world
6. In new quantum-dot LED design, researchers turn troublesome molecules to their advantage
7. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
8. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
9. Multidisciplinary team of researchers develop world’s lightest material
10. K computer research results awarded ACM Gordon Bell Prize
11. ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market

Post Your Comments:

(Date:5/23/2013)... Every day, their baby stopped breathing, his collapsed ... lungs. April and Bryan Gionfriddo watched helplessly, just praying ... a few doctors said he had a good chance ... about her now 20-month-old son, Kaiba. "At that point, ... take it and run with it." , They found ...

(Date:5/23/2013)... Can economic incentives such as gift ... of the public to increase their donations of blood? ... Carey Business School Assistant Professor Mario Macis says ... large body of recent research that supports their argument, ... issue of Science that the World Health Organization and ...

(Date:5/23/2013)... SCHOFIELD, Wis. , May 23, 2013 /PRNewswire/ ... a researcher, developer, and marketer of over-the-counter (OTC) ... re-issued its research opinion on the company based ... Highlights , Non-Prescription, All Natural Product ... Show the Product Outperforms #1 Prescription Competitor ...

(Date:5/23/2013)... 2013 PI’s new LPS-24 positioners ... 15 mm travel range with closed-loop sensor resolution ... make these new positioners the ideal choice for ... rated version is also available. , More ... can be found at: , http://www.physikinstrumente.com/en/products/prdetail.php?sortnr=1000745&prw-lps24 ...

Breaking Biology Technology:Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2 Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3 Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2 Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3 PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2 PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3 Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2

[0] Baby's life saved with groundbreaking 3-D printed device that restored his breathing [0] Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science [0] PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 [0] Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI

... Realty Trust, Inc. (NYSE: BMR ) today announced ... 30, 2010 after the market closes on Wednesday, November 3, ... Executive Officer, Kent Griffin, President, and Greg N. Lubushkin, Chief ... a.m. Pacific Time on Thursday, November 4, 2010 to discuss ...

... 18 Reportlinker.com announces that a new market research ... Global Food Safety Testing Industry ... markets for Food Safety Testing in US$ Million by ... GMO Testing, and Other Testing. The end-use markets also ...

... Oct. 18 NeurogesX, Inc. (Nasdaq: NGSX ... novel pain management therapies, today announced plans to pursue ... to include patients with painful HIV-associated neuropathy (HIV-AN, also ... Following a recent meeting with the U.S. Food ...

BioMed Realty Trust to Report 2010 Third Quarter Results Reportlinker Adds Global Food Safety Testing Industry NeurogesX to Pursue Expanded U.S. Label for Qutenza® (capsaicin) 8% Patch in HIV-Associated Neuropathy

(Date:5/23/2013)... Automated conserved noncoding sequence (CNS) discovery reveals differences ... , Within the genome of each species, there are ... in position and sequence over millions of years, but ... evolutionarily stable sequences, so-called conserved noncoding sequences (CNSs), are ... the condensation of chromosomes, but the function of many ...

(Date:5/23/2013)... suppresses lipid synthesis in the liver, UC Irvine endocrinologists ... liver diseases. , With this finding, Dr. Ellis ... in the field. Study results appear in the May ... , "The dogma in the steroid receptor field for ... the nucleus respond to steroid hormones by regulating genes ...

(Date:5/23/2013)... treating cerebral palsy with autologous cord blood. Following a ... old boy had been in a persistent vegetative state ... after treatment with the cord blood containing stem cells, ... child learned to speak simple sentences and to move. ... dispel the long-held doubts about the effectiveness of the ...

Breaking Biology News(10 mins):Frontiers news briefs: May 23 2 Frontiers news briefs: May 23 3 UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2 First successful treatment of pediatric cerebral palsy with autologous cord blood 2

[0] Frontiers news briefs: May 23 [0] UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis [0] First successful treatment of pediatric cerebral palsy with autologous cord blood

... State University research group is jumping ahead to improve ... childhood obesity. The researchers -- led by David ... a program called HOP,N Home, which stands for Healthy ... researchers have been working on obesity prevention for more ...

... 16, 2011 For the first time, researchers ... effects of the enzymes involved in degrading persistent ... by Professor Michel Sylvestre of Centre INRSInstitut Armand-Frappier ... serve not only to help develop effective biocatalysts ...

... is widely suspected that the current wave of obesity among ... diabetes over the next few decades. But a second systematic ... adult life has shown there is little evidence of a ... remove any risk of lasting harm. This ...

Cached Biology News:Research aims to prevent obesity by reaching parents, young children through child care 2 Research aims to prevent obesity by reaching parents, young children through child care 3 Childhood obesity -- what are the health risks? 2 Childhood obesity -- what are the health risks? 3

Research aims to prevent obesity by reaching parents, young children through child care Zeroing in on more powerful enzymes for degrading persistent pollutants Childhood obesity -- what are the health risks?

... a dramatic breakthrough in accurate, small-volume bulk dispensing. ... the micro 1 has unique advantages not found ... 1 never needs re-calibration as do other 1mL ... an LCD Display , Graphical Row Selection , ...

... offer all of the features of a ... with Koehler illumination, a centerable condenser and ... is the workhorse of Motic's range of ... need for re-focusing following a change in ...

... Primer Manual Cycle Sequencing Kit is designed ... and high-resolution fluorescence scanners. Sequencing reactions involve ... gel electrophoresis and scanning of the gel ... The kit components have been optimized for ...

Rabbit polyclonal to Esa1 ( Abpromise for all tested applications)....

Biology Products:

micro 1 from Hudson Control Group, Inc.DMWB3-223ASC Digital Compound DIN from Motic Instruments, Inc.Thermo Sequenase Dye Primer Manual Cycle Sequencing Kit from USB Corp.Rabbit Anti-Esa1 Polyclonal Antibody, Unconjugated from Abcam